E-Scopics is the only manufacturer that has developed a fully software-based system architecture for ultrasound imaging, which can leverage AI-based processing algorithms. It dematerializes hardware-based ultrasound systems and shifts the paradigm of ultrasound imaging by optimizing image reconstruction, leading to ultra-low consumption transducers and ultrafast imaging capabilities. It democratizes ultrasound imaging through connected Apps that can be adopted by any healthcare professionals. The digital probe communicates with a processing host, a cell phone, a PC or the cloud, to compute multiparametric quantitative images to meet specific diagnostic needs. The commercialization of its first product started in 2024 in the USA and Europe. Hepatoscope is dedicated to the assessment of chronic liver disease using liver stiffness and fat fraction biomarkers. In 2021, the company also licensed its ultrasound platform to a third-party industrial partner for intravascular ultrasound imaging.